La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species

Identifieur interne : 000604 ( Hal/Corpus ); précédent : 000603; suivant : 000605

KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species

Auteurs : Georgios Pampalakis ; Vasia-Samantha Sykioti ; Methodios Ximerakis ; Ioanna Stefanakou-Kalakou ; Ronald Melki ; Kostas Vekrellis ; Georgia Sotiropoulou

Source :

RBID : Hal:hal-01405158

Abstract

KLK6 is a serine protease highly expressed in the nervous system. In synucleinopathies, including Parkinson disease, the levels of KLK6 inversely correlate with α-synuclein in CSF. Recently, we suggested that recombinant KLK6 mediates the degradation of extracellular α-synuclein directly and via a proteolytic cascade that involves unidentified metalloproteinase(s). Here, we show that recombinant and naturally secreted KLK6 can readily cleave α-synuclein fibrils that have the potential for cell-to-cell propagation in "a prion-like mechanism". Importantly, KLK6-deficient primary cortical neurons have increased ability for α-synuclein fibril uptake. We also demonstrate that KLK6 activates proMMP2, which in turn can cleave α-synuclein. The repertoire of proteases activated by KLK6 in a neuronal environment was analyzed by degradomic profiling, which also identified ADAMTS19 and showed that KLK6 has a limited number of substrates indicating specific biological functions such as the regulation of α-synuclein turnover. We generated adenoviral vectors for KLK6 delivery and demonstrated that the levels of extracellular α-synuclein can be reduced by neuronally secreted KLK6. Our findings open the possibility to exploit KLK6 as a novel therapeutic target for Parkinson disease and other synucleinopathies.

Url:
DOI: 10.18632/oncotarget.13264

Links to Exploration step

Hal:hal-01405158

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species</title>
<author>
<name sortKey="Pampalakis, Georgios" sort="Pampalakis, Georgios" uniqKey="Pampalakis G" first="Georgios" last="Pampalakis">Georgios Pampalakis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sykioti, Vasia Samantha" sort="Sykioti, Vasia Samantha" uniqKey="Sykioti V" first="Vasia-Samantha" last="Sykioti">Vasia-Samantha Sykioti</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ximerakis, Methodios" sort="Ximerakis, Methodios" uniqKey="Ximerakis M" first="Methodios" last="Ximerakis">Methodios Ximerakis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Stefanakou Kalakou, Ioanna" sort="Stefanakou Kalakou, Ioanna" uniqKey="Stefanakou Kalakou I" first="Ioanna" last="Stefanakou-Kalakou">Ioanna Stefanakou-Kalakou</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Melki, Ronald" sort="Melki, Ronald" uniqKey="Melki R" first="Ronald" last="Melki">Ronald Melki</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-418266" status="VALID">
<orgName>Institut des Neurosciences de Paris-Saclay</orgName>
<orgName type="acronym">Neuro-PSI</orgName>
<desc>
<address>
<addrLine>Centre National de la Recherche Scientifique, Unité Mixte de Recherche-9197 Université Paris-Sudbâtiment 32 Campus de Recherche de Gif-sur-Yvette1, avenue de la Terrasse91198 Gif-sur-Yvette</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://neuro-psi.fr</ref>
</desc>
<listRelation>
<relation active="#struct-92966" type="direct"></relation>
<relation name="UMR9197" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-92966" type="direct">
<org type="institution" xml:id="struct-92966" status="VALID">
<orgName>Université Paris-Sud - Paris 11</orgName>
<orgName type="acronym">UP11</orgName>
<desc>
<address>
<addrLine>Bâtiment 300 - 91405 Orsay cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-psud.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR9197" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vekrellis, Kostas" sort="Vekrellis, Kostas" uniqKey="Vekrellis K" first="Kostas" last="Vekrellis">Kostas Vekrellis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sotiropoulou, Georgia" sort="Sotiropoulou, Georgia" uniqKey="Sotiropoulou G" first="Georgia" last="Sotiropoulou">Georgia Sotiropoulou</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01405158</idno>
<idno type="halId">hal-01405158</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01405158</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01405158</idno>
<idno type="doi">10.18632/oncotarget.13264</idno>
<date when="2016-11-10">2016-11-10</date>
<idno type="wicri:Area/Hal/Corpus">000604</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species</title>
<author>
<name sortKey="Pampalakis, Georgios" sort="Pampalakis, Georgios" uniqKey="Pampalakis G" first="Georgios" last="Pampalakis">Georgios Pampalakis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sykioti, Vasia Samantha" sort="Sykioti, Vasia Samantha" uniqKey="Sykioti V" first="Vasia-Samantha" last="Sykioti">Vasia-Samantha Sykioti</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ximerakis, Methodios" sort="Ximerakis, Methodios" uniqKey="Ximerakis M" first="Methodios" last="Ximerakis">Methodios Ximerakis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Stefanakou Kalakou, Ioanna" sort="Stefanakou Kalakou, Ioanna" uniqKey="Stefanakou Kalakou I" first="Ioanna" last="Stefanakou-Kalakou">Ioanna Stefanakou-Kalakou</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Melki, Ronald" sort="Melki, Ronald" uniqKey="Melki R" first="Ronald" last="Melki">Ronald Melki</name>
<affiliation>
<hal:affiliation type="laboratory" xml:id="struct-418266" status="VALID">
<orgName>Institut des Neurosciences de Paris-Saclay</orgName>
<orgName type="acronym">Neuro-PSI</orgName>
<desc>
<address>
<addrLine>Centre National de la Recherche Scientifique, Unité Mixte de Recherche-9197 Université Paris-Sudbâtiment 32 Campus de Recherche de Gif-sur-Yvette1, avenue de la Terrasse91198 Gif-sur-Yvette</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://neuro-psi.fr</ref>
</desc>
<listRelation>
<relation active="#struct-92966" type="direct"></relation>
<relation name="UMR9197" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-92966" type="direct">
<org type="institution" xml:id="struct-92966" status="VALID">
<orgName>Université Paris-Sud - Paris 11</orgName>
<orgName type="acronym">UP11</orgName>
<desc>
<address>
<addrLine>Bâtiment 300 - 91405 Orsay cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u-psud.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR9197" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vekrellis, Kostas" sort="Vekrellis, Kostas" uniqKey="Vekrellis K" first="Kostas" last="Vekrellis">Kostas Vekrellis</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474027" status="INCOMING">
<orgName>Center for Neurosciences, Biomedical Research Foundation</orgName>
<desc>
<address>
<addrLine>Academy of Athens, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sotiropoulou, Georgia" sort="Sotiropoulou, Georgia" uniqKey="Sotiropoulou G" first="Georgia" last="Sotiropoulou">Georgia Sotiropoulou</name>
<affiliation>
<hal:affiliation type="institution" xml:id="struct-474026" status="INCOMING">
<orgName>Department of Pharmacy, School of Health Sciences</orgName>
<desc>
<address>
<addrLine>University of Patras, Rion-Patras, Athens</addrLine>
<country key="GR"></country>
</address>
</desc>
</hal:affiliation>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.18632/oncotarget.13264</idno>
<series>
<title level="j">Oncotarget</title>
<idno type="ISSN">1949-2553</idno>
<imprint>
<date type="datePub">2016-11-10</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">KLK6 is a serine protease highly expressed in the nervous system. In synucleinopathies, including Parkinson disease, the levels of KLK6 inversely correlate with α-synuclein in CSF. Recently, we suggested that recombinant KLK6 mediates the degradation of extracellular α-synuclein directly and via a proteolytic cascade that involves unidentified metalloproteinase(s). Here, we show that recombinant and naturally secreted KLK6 can readily cleave α-synuclein fibrils that have the potential for cell-to-cell propagation in "a prion-like mechanism". Importantly, KLK6-deficient primary cortical neurons have increased ability for α-synuclein fibril uptake. We also demonstrate that KLK6 activates proMMP2, which in turn can cleave α-synuclein. The repertoire of proteases activated by KLK6 in a neuronal environment was analyzed by degradomic profiling, which also identified ADAMTS19 and showed that KLK6 has a limited number of substrates indicating specific biological functions such as the regulation of α-synuclein turnover. We generated adenoviral vectors for KLK6 delivery and demonstrated that the levels of extracellular α-synuclein can be reduced by neuronally secreted KLK6. Our findings open the possibility to exploit KLK6 as a novel therapeutic target for Parkinson disease and other synucleinopathies.</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species</title>
<author role="aut">
<persName>
<forename type="first">Georgios</forename>
<surname>Pampalakis</surname>
</persName>
<idno type="halauthorid">1423620</idno>
<affiliation ref="#struct-474026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Vasia-Samantha</forename>
<surname>Sykioti</surname>
</persName>
<idno type="halauthorid">1423621</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Methodios</forename>
<surname>Ximerakis</surname>
</persName>
<idno type="halauthorid">1423622</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Ioanna</forename>
<surname>Stefanakou-Kalakou</surname>
</persName>
<idno type="halauthorid">1423623</idno>
<affiliation ref="#struct-474026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Ronald</forename>
<surname>Melki</surname>
</persName>
<idno type="halauthorid">190086</idno>
<affiliation ref="#struct-418266"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Kostas</forename>
<surname>Vekrellis</surname>
</persName>
<idno type="halauthorid">1423624</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Georgia</forename>
<surname>Sotiropoulou</surname>
</persName>
<idno type="halauthorid">1343467</idno>
<affiliation ref="#struct-474026"></affiliation>
<affiliation ref="#struct-474027"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Alain</forename>
<surname>PERIGNON</surname>
</persName>
<email type="md5">0915a8bc0b5a494fc86eb9724296445c</email>
<email type="domain">cnrs.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2016-11-29 15:42:34</date>
<date type="whenModified">2017-02-17 14:25:08</date>
<date type="whenReleased">2016-11-29 15:42:34</date>
<date type="whenProduced">2016-11-10</date>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="108746">
<persName>
<forename>Alain</forename>
<surname>PERIGNON</surname>
</persName>
<email type="md5">0915a8bc0b5a494fc86eb9724296445c</email>
<email type="domain">cnrs.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-01405158</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01405158</idno>
<idno type="halBibtex">pampalakis:hal-01405158</idno>
<idno type="halRefHtml">Oncotarget, Impact journals, 2016, ahead of print, <10.18632/oncotarget.13264></idno>
<idno type="halRef">Oncotarget, Impact journals, 2016, ahead of print, <10.18632/oncotarget.13264></idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="UNIV-PSUD">Université Paris Sud - Paris XI</idno>
<idno type="stamp" n="UNIV-PSUD-SACLAY" p="UNIV-PARIS-SACLAY">Université Paris Sud pour Paris Saclay</idno>
<idno type="stamp" n="UNIV-PARIS-SACLAY">Université Paris-Saclay</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species</title>
<author role="aut">
<persName>
<forename type="first">Georgios</forename>
<surname>Pampalakis</surname>
</persName>
<idno type="halauthorid">1423620</idno>
<affiliation ref="#struct-474026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Vasia-Samantha</forename>
<surname>Sykioti</surname>
</persName>
<idno type="halauthorid">1423621</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Methodios</forename>
<surname>Ximerakis</surname>
</persName>
<idno type="halauthorid">1423622</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Ioanna</forename>
<surname>Stefanakou-Kalakou</surname>
</persName>
<idno type="halauthorid">1423623</idno>
<affiliation ref="#struct-474026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Ronald</forename>
<surname>Melki</surname>
</persName>
<idno type="halauthorid">190086</idno>
<affiliation ref="#struct-418266"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Kostas</forename>
<surname>Vekrellis</surname>
</persName>
<idno type="halauthorid">1423624</idno>
<affiliation ref="#struct-474027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Georgia</forename>
<surname>Sotiropoulou</surname>
</persName>
<idno type="halauthorid">1343467</idno>
<affiliation ref="#struct-474026"></affiliation>
<affiliation ref="#struct-474027"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">102112</idno>
<idno type="issn">1949-2553</idno>
<title level="j">Oncotarget</title>
<imprint>
<publisher>Impact journals</publisher>
<biblScope unit="volume">ahead of print</biblScope>
<date type="datePub">2016-11-10</date>
</imprint>
</monogr>
<idno type="doi">10.18632/oncotarget.13264</idno>
<idno type="pubmed">27845893</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<classCode scheme="halDomain" n="sdv.neu.nb">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology</classCode>
<classCode scheme="halDomain" n="sdv.neu.pc">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior</classCode>
<classCode scheme="halDomain" n="sdv.neu.sc">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">KLK6 is a serine protease highly expressed in the nervous system. In synucleinopathies, including Parkinson disease, the levels of KLK6 inversely correlate with α-synuclein in CSF. Recently, we suggested that recombinant KLK6 mediates the degradation of extracellular α-synuclein directly and via a proteolytic cascade that involves unidentified metalloproteinase(s). Here, we show that recombinant and naturally secreted KLK6 can readily cleave α-synuclein fibrils that have the potential for cell-to-cell propagation in "a prion-like mechanism". Importantly, KLK6-deficient primary cortical neurons have increased ability for α-synuclein fibril uptake. We also demonstrate that KLK6 activates proMMP2, which in turn can cleave α-synuclein. The repertoire of proteases activated by KLK6 in a neuronal environment was analyzed by degradomic profiling, which also identified ADAMTS19 and showed that KLK6 has a limited number of substrates indicating specific biological functions such as the regulation of α-synuclein turnover. We generated adenoviral vectors for KLK6 delivery and demonstrated that the levels of extracellular α-synuclein can be reduced by neuronally secreted KLK6. Our findings open the possibility to exploit KLK6 as a novel therapeutic target for Parkinson disease and other synucleinopathies.</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000604 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000604 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:hal-01405158
   |texte=   KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024